I want to remind everyone of this: It seems lik
Post# of 36537
(Total Views: 314)
Posted On: 01/09/2021 4:05:05 PM
I want to remind everyone of this:
It seems like they might already have an idea on how they are going to set this price.
I'm really not that worried about this as we finally have this going now. Before everything was speculative. Now, there is an actual dollar value and they are setting a PPS to list. We don't know how, but it seems like they do have something in the works.
Remember also, they just received 100,000 from the Chinese deal and they will be receiving another 5 million as well. So, we know the valuation will keep going up from now until February 5th as well. So, Joe said upwards of 500 million, add 100,000 then add another 5 million at least then whatever comes on top of that.
From the PR
I will update everyone on our progress and timing on the NuGenerex Immuno-Oncology Nasdaq listing now that our third-party valuation analysis has been completed with a value estimated at over $500 million. This third-party valuation report is the last piece of information required to enable us to set the price per share to meet the standards for the Nasdaq.
Read More: https://investorshangout.com/post/view?id=601...z6j5PRVz3e
It seems like they might already have an idea on how they are going to set this price.
I'm really not that worried about this as we finally have this going now. Before everything was speculative. Now, there is an actual dollar value and they are setting a PPS to list. We don't know how, but it seems like they do have something in the works.
Remember also, they just received 100,000 from the Chinese deal and they will be receiving another 5 million as well. So, we know the valuation will keep going up from now until February 5th as well. So, Joe said upwards of 500 million, add 100,000 then add another 5 million at least then whatever comes on top of that.
From the PR
I will update everyone on our progress and timing on the NuGenerex Immuno-Oncology Nasdaq listing now that our third-party valuation analysis has been completed with a value estimated at over $500 million. This third-party valuation report is the last piece of information required to enable us to set the price per share to meet the standards for the Nasdaq.
Read More: https://investorshangout.com/post/view?id=601...z6j5PRVz3e
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼